Product News and Recalls

Eli Lilly and Co pleads guilty to Medicaid fraud claims based on off-label promotion of Zyprexa.

JANUARY 15, 2009 – Eli Lilly and Co, under criminal and civil investigation concerning the drug Zyprexa, has pleaded guilty to violation of federal law and settled Medicaid fraud claims based on off-label promotion of Zyprexa. The drug was approved for the treatment of schizophrenia but was promoted by Eli Lilly for unapproved uses, including dementia—especially in the elderly. Due to the drug’s propensity to cause diabetes, this led to many patients unnecessarily taking Zyprexa and suffering serious physical illnesses, including death. Lopez McHugh’s own Ramon Lopez was one of the lead attorneys who settled the nationwide Zyprexa personal injury suits.